“…In recent years, great research interest has focused on the technology and materials of afterglow luminescent imaging. ,, As compared to the widely used fluorescence imaging, afterglow imaging does not require real-time external light excitation, therefore leading to negligible autofluorescence, higher sensitivity, and deeper imaging depth. , To date, two categories of afterglow agents have been developed: (1) inorganic afterglow materials containing rare-earth metal such as europium and praseodymium and 2) organic afterglow materials including semiconducting polymer (e.g., poly[2-methoxy-5-(2-ethylhexyloxy)-1,4-phenylenevinylene])-based and small molecule (e.g., Schaap’s dioxetane)-based ones. − Nevertheless, the inorganic and organic afterglow materials capable of responding to the disease biomarkers/microenvironments selectively remain limited . Among versatile afterglow agents, Schaap’s dioxetane-based agents in particular the ones developed by Shabat and co-workers exhibit distinctive merits including facile synthesis and modification, bright afterglow luminescence in water, and convenience to build activatable afterglow probes. ,,− A number of activatable afterglow probes based on Schaap’s dioxetane by caging the phenol group with specific responsive moieties have been developed to visualize the targets such as cathepsins, hydrogen peroxide (H 2 O 2 ), and formaldehyde. ,, Recently, significant efforts have been contributed to red shift the Schaap’s dioxetane-based afterglow luminescence in a physiological environment, such as conjugation with conventional near-infrared (NIR) fluorophores, changing the substituent in the phenol core, and nanoparticle formulation. ,, Despite these exciting pioneer studies, there is still room left to improve the luminescent brightness and afterglow time in NIR region (>650 nm) for advanced in vivo applications.…”